Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study

AIM: To evaluate the effectiveness of dexamethasone intravitreal implant 0.7 mg (DEX; Ozurdex) monotherapy in the patient subgroup of the AUSSIEDEX study with treatment-naïve diabetic macular oedema (DME). METHODS: The open-label, prospective, phase 4, real-world study included pseudophakic eyes and...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraser-Bell, Samantha, Kang, Hyong Kwon, Mitchell, Paul, Arnold, Jennifer J, Tainton, Jodi, Simonyi, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763166/
https://www.ncbi.nlm.nih.gov/pubmed/34433549
http://dx.doi.org/10.1136/bjophthalmol-2021-319070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763166/
https://www.ncbi.nlm.nih.gov/pubmed/34433549
http://dx.doi.org/10.1136/bjophthalmol-2021-319070

Ejemplares similares